Neurogene Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2017 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Neurogene Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2017 to Q3 2024.
  • Neurogene Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 17M shares, a 3699% increase year-over-year.
  • Neurogene Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 55.2M shares, a 0.33% increase from 2021.
  • Neurogene Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 55M shares, a 6.21% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 17M +16.5M +3699% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-18
Q2 2024 16.9M +16.5M +3712% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 16.9M -38.5M -69.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 4.66M -50.6M -91.6% Dec 19, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 446K -10.6M -96% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-18
Q2 2023 444K -54.8M -99.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 55.4M +277K +0.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-08
Q4 2022 55.2M +179K +0.33% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-20
Q3 2022 11.1M -44M -79.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 55.2M +177K +0.32% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 55.1M +199K +0.36% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 55M +3.22M +6.21% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 55.1M +966K +1.79% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 55M +5.63M +11.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 54.9M +5.78M +11.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 51.8M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 54.1M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 49.4M +25.9M +110% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 49.2M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q2 2019 23.5M -309K -1.3% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-01
Q2 2018 23.8M +402K +1.72% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q2 2017 23.4M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.